ReviewJournal of molecular medicine (Berlin, Germany)2010

Rapamycin and the transcription factor C/EBPbeta as a switch in osteoclast differentiation: implications for lytic bone diseases.

Jeske J Smink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.